Clinical and Translational Research
Copyright ©The Author(s) 2021.
World J Gastroenterol. Jun 7, 2021; 27(21): 2871-2894
Published online Jun 7, 2021. doi: 10.3748/wjg.v27.i21.2871
Figure 6
Figure 6 Gene set enrichment analysis identified gene sets that were different between the high-risk-score group and low-risk-score group in stomach adenocarcinoma. A: The ECM receptor interaction pathway was significantly different between the high-risk-score group and low-risk-score group; B: The cytokine and cytokine receptor interaction pathway was significantly different between the high-risk-score group and low-risk-score group; C: The MAPK signaling pathway was significantly different between the high-risk-score group and low-risk-score group; D: The spliceosome pathway was significantly different between the high-risk-score group and low-risk-score group; E: The cell cycle pathway was significantly different between the high-risk-score group and low-risk-score group; F: The proteasome pathway was significantly different between the high-risk-score group and low-risk-score group.